Literature DB >> 7586394

Long-term clinical and echocardiographic follow-up after surgical correction of hypertrophic obstructive cardiomyopathy with extended myectomy and reconstruction of the subvalvular mitral apparatus.

F A Schoendube1, H G Klues, S Reith, F A Flachskampf, P Hanrath, B J Messmer.   

Abstract

BACKGROUND: The standard surgical approach to hypertrophic obstructive cardiomyopathy (HOCM) was modified in the present series with a combination of extended myectomy with partial excision and mobilization of the papillary muscles. METHODS AND
RESULTS: Between 1979 and 1992, 58 patients (38 men and 20 women; mean age, 49 +/- 24 years) with HOCM were operated on with the use of this different technique. Their intraventricular gradients were 79 +/- 33 (+/- SD) mm Hg at rest and increased to 147 +/- 48 mm Hg with provocative maneuvers. Mild-to-moderate mitral regurgitation was present in 60% of the patients, and severe regurgitation was present in 5%. Ten patients required additional aortocoronary bypass graft surgery. Follow-up (mean, 84 months) was complete (100%). Hemodynamic improvement was documented by a significant (P < .01) decrease in left ventricular end-diastolic pressure from 19 +/- 9 to 14 +/- 6 mm Hg and reduction of basal outflow tract gradients to 5 +/- 7 mm Hg at rest and 16 +/- 24 mm Hg after provocation. Late mortality was 1.4% per patient-year, and no sudden cardiac deaths occurred during follow-up. Functional status was excellent for 84% of the patients; 8 patients were in New York Heart Association functional class III, and none were in class IV. Echocardiography revealed no outflow tract obstruction.
CONCLUSIONS: Extended myectomy and reconstruction of the subvalvular mitral apparatus in HOCM result in excellent functional improvement with relief of outflow tract obstruction. The technique can be performed safely despite its more aggressive surgical nature and allows an individualized strategy depending on the patient's extent and distribution of left ventricular hypertrophy.

Entities:  

Mesh:

Year:  1995        PMID: 7586394     DOI: 10.1161/01.cir.92.9.122

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  26 in total

Review 1.  Current status of alcohol septal ablation for patients with hypertrophic cardiomyopathy.

Authors:  H Seggewiss
Journal:  Curr Cardiol Rep       Date:  2001-03       Impact factor: 2.931

Review 2.  Transcatheter septal ablation in hypertrophic obstructive cardiomyopathy: a technical guide and review of published results.

Authors:  Angelos G Rigopoulos; Stefanos Sakellaropoulos; Muhammad Ali; Sophie Mavrogeni; Athanassios Manginas; Matthias Pauschinger; Michel Noutsias
Journal:  Heart Fail Rev       Date:  2018-11       Impact factor: 4.214

3.  Surgery for hypertrophic obstructive cardiomyopathy (HOCM): what to do with concomitant mitral insufficiency?

Authors:  Bruno J Messmer
Journal:  J Thorac Dis       Date:  2017-04       Impact factor: 2.895

4.  Surgery for hypertrophic cardiomyopathy.

Authors:  James J Wu; Michael Seco; Caroline Medi; Chris Semsarian; David R Richmond; Joseph A Dearani; Hartzell V Schaff; Michael J Byrom; Paul G Bannon
Journal:  Biophys Rev       Date:  2015-01-10

5.  Hypertrophic obstructive cardiomyopathy-the Leipzig experience.

Authors:  Jawad Khalil; Michael Kuehl; Pirose Davierwala; Friedrich Wilhelm Mohr; Martin Misfeld
Journal:  Ann Cardiothorac Surg       Date:  2017-07

6.  Surgical outcomes and strategy of hypertrophic obstructive cardiomyopathy.

Authors:  Ya-bin Zhu; S Rajan; V M Kurian; Zhi-yong Liu
Journal:  J Zhejiang Univ Sci B       Date:  2006-02       Impact factor: 3.066

Review 7.  The mitral valve in hypertrophic cardiomyopathy: old versus new concepts.

Authors:  Albert A Hagège; Patrick Bruneval; Robert A Levine; Michel Desnos; Hany Neamatalla; Daniel P Judge
Journal:  J Cardiovasc Transl Res       Date:  2011-09-10       Impact factor: 4.132

Review 8.  Management of hypertrophic cardiomyopathy in children.

Authors:  Hubert Seggewiss; Angelos Rigopoulos
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

9.  Long-term follow-up after percutaneous septal ablation in hypertrophic obstructive cardiomyopathy.

Authors:  H Seggewiss; A Rigopoulos; D Welge; P Ziemssen; L Faber
Journal:  Clin Res Cardiol       Date:  2007-09-27       Impact factor: 5.460

10.  Myocardial ischemia with left ventricular outflow obstruction.

Authors:  Aron F Popov; Christian Bireta; Jan D Schmitto; Dieter Zenker; Martin Friedrich; Kasim O Coskun; Ralf Seipelt; Gerd G Hanekop; Friedrich A Schoendube
Journal:  J Cardiothorac Surg       Date:  2009-09-17       Impact factor: 1.637

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.